Your opportunity to connect directly with the virology sector
If you would like us to create a package aligned to your marketing needs, please contact Kim kim@laevents.com.au | 61 3 6234 7844
Our Sponsors
Major Sponsor
Seqirus has public health protection at its core, reflecting the promise of our parent company – CSL Limited – which was founded in 1916 to save lives and protect the health of people. Together with our partners on the front line, we have served Australia’s healthcare needs for over a century. Today we develop, manufacture and source medicines that support the health and well-being of many thousands of people around the world. Seqirus operates Australia’s only local manufacturing facility for seasonal and pandemic influenza vaccine, and produces a range of unique medicines in the national interest including antivenoms and Q fever vaccine. Seqirus also in-licenses a broad range of paediatric and adult vaccines and specialty pharmaceutical products.
Welcome Mixer Sponsor
AnteoTech specialises in surface chemistry modification, with innovative patented nano-technology in two sectors, Point of Care Diagnostics (POC) and Clean Energy. Our proprietary nano-polymer coating, AnteoBind helps bind macromolecules such as viral particles to users in academia and Life Science sectors. AnteoBind is an alternative technology to conventional conjugation chemistry, improving biomolecule binding capacity, reproducibility and stability, leading to higher analytical sensitivity. AnteoBind has been proven in Bio-separation, Multiplexing and Lateral Flow development applications.
Opening International Keynote Speaker Sponsor
GSK is now a fully focussed biopharma company with a new purpose: to unite science, technology, and talent to get ahead of disease together. We aim to impact the health of 2.5 billion people over the next 10 years. We will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccine and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology including respiratory diseases.
For more information visit au.gsk.com
Name Badge Sponsor
Moderna’s Mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. The company was founded in 2010, focused on building the leading mRNA technology platform, infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team. Our pipeline includes development candidates for mRNA-based vaccines and therapies spanning several therapeutic areas, with multiple clinical trials underway and other development candidates progressing toward the clinic. In addition, there are numerous discovery programs advancing toward development.
Poster Session Sponsor
Comprising over 200 researchers, students and support staff, the Institute for Glycomics strives to be a world leader in the discovery and development of next generation drugs, vaccines and diagnostics for diseases of global impact.
Established in 2000, the Institute for Glycomics is one of Australia’s flagship interdisciplinary translational biomedical research institutes, based at Griffith University’s Gold Coast campus. The Institute’s research primarily targets identification, prevention and cures for cancers, infectious diseases, and neurodegenerative disorders.
Breakfast Career Development Session Sponsor
Microorganisms (ISSN 2076-2607) is an international, peer-reviewed, open access journal that provides an advanced forum for studies related to prokaryotic and eukaryotic microorganisms, viruses and prions. It has been covered by some leading indexing services, including the Science Citation Index Expanded (Web of Science), PubMed, PMC and many other databases. All manuscripts are peer-reviewed and a first decision provided to authors approximately 12.7 days after submission; acceptance to publication is undertaken in 2.9 days.
WiFi Sponsor
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights.
Our mission is to make improvements in life possible by enabling our customers to achieve outstanding success and breakthroughs in life sciences research, applied testing, pharma and molecular diagnostics.
Further information can be found at www.qiagen.com
Poster Session Sponsor
The needle-free future of vaccination.
An advanced platform that vaccinates by applying a patch to the skin for a few seconds. Engineered to directly deposit vaccine amongst dense population of key immune cells in the skin, developing an efficient and effective immune response.
Engineered to be better.
Better scientifically. Better for patients. Better for safety.
Electronic Handbook & Program Sponsor
Eppendorf is a leading life science company that develops and supplies innovative solutions for liquid-, sample-, and cell handling in laboratories worldwide. Our products include pipettes and automated pipetting systems, centrifuges, thermal cyclers, ULT freezers, CO2 incubators and shakers as well as premium pipette tips, Eppendorf tubes and plates. We’re committed to providing reliable services and tools to support your applications and help you maintain premium performance and longevity of our systems.
Visit Eppendorf’s website: www.eppendorf.com.au
Session and Travel Award Sponsor – Viral Epidemiology and Diagnostics and Viral Immunology/ Indigenous Researcher Sponsor
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Session Sponsor – Antivirals and Vaccines
Burnet Institute is an Australian, independent, not-for-profit organisation. Its mission is to achieve better health for vulnerable communities by accelerating the translation of research, discovery and evidence into sustainable health solutions. Burnet brings together a highly diverse skill base of medical researchers, public health and international development professionals with a key focus on Infectious Disease Elimination, Maternal, Child and Adolescent Health, Behaviours and Health Risks, and Health Security.
Session Sponsor – Indigenous Virology/ Travel Award Sponsor
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why The University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – have partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
Session Sponsor – Unusual Viruses, Phages and Plant Viruses/ Student Travel Award/ Student/ECR Award
We’re on a mission to save lives with phage therapy
Phage Australia is a network of phage researchers and clinician scientists aiming to professionalise phage therapy as the third major intervention for infectious diseases, after vaccines and antibiotics. We’re building a national ecosystem that integrates phage biobanking, rapid phage diagnostics, phage manufacturing, and an adaptive clinical trial framework that fits the context of personalised phage therapy.
Our team’s combined expertise spans infectious disease, phage biology, biobanking, genomics and data science, and we represent major medical and academic centres from across Australia. We’ve safely applied phages across multiple clinical indications and pathogens i.e., by working closely with the Australian Therapeutic Goods Administration (TGA), our team has safely treated 15 adults and 3 children with phage therapy in conjunction with antibiotics.
Travel Award Sponsor
Finding solutions to prevent, treat and cure infectious diseases and understanding the complexities of microbes and the immune system requires innovative approaches and concentrated effort. This is why The University of Melbourne – a world leader in education, teaching and research excellence – and The Royal Melbourne Hospital – an internationally renowned institution providing outstanding care, research and learning – have partnered to create the Peter Doherty Institute for Infection and Immunity (Doherty Institute); a centre of excellence where leading scientists and clinicians collaborate to improve human health globally.
biomedicalsciences.unimelb.edu.au/departments/microbiology-Immunology
Travel Award Sponsor
School of Biomedical Sciences is a vibrant ecosystem of educators, researchers and professionals, all working at the coalface of health and medical sciences. As teachers, scientists, clinicians and support staff, school members are driven by a collective desire to take the best ideas and turn them into transformational impacts in medicine and health, not just in Australia but globally, too.
Destination Partner
Our Exhibitors
AnteoTech specialises in surface chemistry modification, with innovative patented nano-technology in two sectors, Point of Care Diagnostics (POC) and Clean Energy. Our proprietary nano-polymer coating, AnteoBind helps bind macromolecules such as viral particles to users in academia and Life Science sectors. AnteoBind is an alternative technology to conventional conjugation chemistry, improving biomolecule binding capacity, reproducibility and stability, leading to higher analytical sensitivity. AnteoBind has been proven in Bio-separation, Multiplexing and Lateral Flow development applications.
Eppendorf is a leading life science company that develops and supplies innovative solutions for liquid-, sample-, and cell handling in laboratories worldwide. Our products include pipettes and automated pipetting systems, centrifuges, thermal cyclers, ULT freezers, CO2 incubators and shakers as well as premium pipette tips, Eppendorf tubes and plates. We’re committed to providing reliable services and tools to support your applications and help you maintain premium performance and longevity of our systems.
Visit Eppendorf’s website: www.eppendorf.com.au
Comprising over 200 researchers, students and support staff, the Institute for Glycomics strives to be a world leader in the discovery and development of next generation drugs, vaccines and diagnostics for diseases of global impact.
Established in 2000, the Institute for Glycomics is one of Australia’s flagship interdisciplinary translational biomedical research institutes, based at Griffith University’s Gold Coast campus. The Institute’s research primarily targets identification, prevention and cures for cancers, infectious diseases, and neurodegenerative disorders.
GSK is now a fully focussed biopharma company with a new purpose: to unite science, technology, and talent to get ahead of disease together. We aim to impact the health of 2.5 billion people over the next 10 years. We will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccine and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology including respiratory diseases.
For more information visit au.gsk.com
Moderna’s Mission is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients. The company was founded in 2010, focused on building the leading mRNA technology platform, infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team. Our pipeline includes development candidates for mRNA-based vaccines and therapies spanning several therapeutic areas, with multiple clinical trials underway and other development candidates progressing toward the clinic. In addition, there are numerous discovery programs advancing toward development.
Created “by scientists for scientists”, NEB is renowned for providing exceptional product quality and unsurpassed technical support. We offer the largest selection of recombinant and native enzymes for genomic research. Our ever-expanding catalogue also includes products related to PCR, gene expression, NGS, synthetic biology, glycobiology, epigenetics and RNA analysis. NEB Australia is also a distributor for Cell Signaling Technology, a manufacturer of antibodies and related reagents for studying the molecular pathways that impact human health.
The needle-free future of vaccination.
An advanced platform that vaccinates by applying a patch to the skin for a few seconds. Engineered to directly deposit vaccine amongst dense population of key immune cells in the skin, developing an efficient and effective immune response.
Engineered to be better.
Better scientifically. Better for patients. Better for safety.